In ccRCC tumors, SETD2 is ubiquitously haploinsufficient (>95%) as a consequence of the loss of the short of arm of chromosome 3 (3p), a phenomenon widely accepted as an early event in ccRCC transformation [5]. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.